Showing results (941-950 of 3,473) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|May 21, 2015
Population Pharmacokinetics of Darbepoetin Alfa in Conjunction with Hypothermia for the Treatment of Neonatal Hypoxic-Ischemic EncephalopathyJessica K Roberts, Chris Stockmann, Robert M Ward, et al.Clinical Pharmacokinetics|May 6, 2015
A critical review on the clinical pharmacokinetics, pharmacodynamics, and clinical trials of ceftarolineTony K L Kiang, Kyle J Wilby, Mary H H EnsomClinical Pharmacokinetics|April 20, 2020
Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety PropertiesCornelis Smit, Mariska Y M Peeters, John N van den Anker, et al.Clinical Pharmacokinetics|October 27, 2019
Drug Exposure to Establish Pharmacokinetic-Response Relationships in OncologyBelén P Solans, María Jesús Garrido, Iñaki F TrocónizClinical Pharmacokinetics|August 13, 2016
Pharmacokinetics, Biotransformation, and Excretion of [14C]Etelcalcetide (AMG 416) Following a Single Microtracer Intravenous Dose in Patients with Chronic Kidney Disease on HemodialysisRaju Subramanian, Xiaochun Zhu, M Benjamin Hock, et al.Clinical Pharmacokinetics|April 19, 2020
Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase InhibitorAngela Joubert James, Catherine C Smith, Mark Litzow, et al.Clinical Pharmacokinetics|March 10, 2004
Pharmacokinetic considerations in development of a bioartificial liverHiroo Iwata, Yuichiro UedaClinical Pharmacokinetics|March 10, 2004
Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patientsChantal Le Guellec, Hélène Bourgoin, Matthias Büchler, et al.Clinical Pharmacokinetics|May 1, 1992
Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapyM Burnier, J BiollazClinical Pharmacokinetics|May 1, 1992
Pharmacokinetics of factor VIII in humans. Obtaining clinically relevant data from comparative studiesS Björkman, M Carlsson, E Berntorp, et al.Pageof 348